Therapeutic radiometals beyond 177Lu and 90Y: Production and application of promising α-particle, β--particle, and auger electron emitters

64Citations
Citations of this article
131Readers
Mendeley users who have this article in their library.

Abstract

In recent years, new α-particle-, β--particle-, and Auger electron- emitting radiometals-such as 67Cu, 47Sc, 166Ho, 161Tb, 149Tb, 212Pb/212Bi, 225Ac, and 213Bi-have been produced and evaluated (pre)clinically for therapeutic purposes. In this short review article, the most important routes of production of these radiometals are critically discussed, as are examples of their application in preclinical and clinical studies.

References Powered by Scopus

<sup>225</sup>Ac-PSMA-617 for PSMA-targeted a-radiation therapy of metastatic castration-resistant prostate cancer

802Citations
N/AReaders
Get full text

Tumor therapy with targeted atomic nanogenerators

432Citations
N/AReaders
Get full text

<sup>213</sup>Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

329Citations
N/AReaders
Get full text

Cited by Powered by Scopus

New developments in the production of theranostic pairs of radionuclides

131Citations
N/AReaders
Get full text

Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine

122Citations
N/AReaders
Get full text

Rhenium-188 labeled radiopharmaceuticals: Current clinical applications in oncology and promising perspectives

115Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Müller, C., Van Der Meulen, N. P., Benešová, M., & Schibli, R. (2017, September 1). Therapeutic radiometals beyond 177Lu and 90Y: Production and application of promising α-particle, β--particle, and auger electron emitters. Journal of Nuclear Medicine. Society of Nuclear Medicine Inc. https://doi.org/10.2967/jnumed.116.186825

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘2409182736

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 46

55%

Researcher 29

35%

Professor / Associate Prof. 6

7%

Lecturer / Post doc 2

2%

Readers' Discipline

Tooltip

Chemistry 37

54%

Medicine and Dentistry 14

20%

Physics and Astronomy 13

19%

Pharmacology, Toxicology and Pharmaceut... 5

7%

Save time finding and organizing research with Mendeley

Sign up for free
0